Lunsumio
- Product NDC
- 50242-142
- 11-digit product format
- 502420142
- Labeler code
- 50242
- Product ID
- 50242-142_2800ba90-bfda-4932-9aae-9ef9166cd7e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mosunetuzumab
- Dosage form
- CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Genentech, Inc.
- Application
- BLA761263
- Marketing category
- BLA
- Marketing start
- 2022-12-22
- Substance
- MOSUNETUZUMAB
- Active strength
- 30 mg/30mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lunsumio
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MOSUNETUZUMAB | 30 mg/30mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | LDJ89SS0YG |
| Rxcui | 2625129, 2625135, 2625137, 2625138 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50242-142-01 | Lunsumio | 30 mL in 1 VIAL | CONCENTRATE | 30 | 6 | |
| 50242-142-01 | Lunsumio | 1 in 1 CARTON | CONCENTRATE | 1 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50242-142-01 | ML - Milliliter | 50242-142 | 292c4650-e022-4ca2-96fb-cfc38e35c8b6 | 1 | 2023-01-09 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2625135 | Lunsumio 1 MG in 1 ML Injection | PSN | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625138 | Lunsumio 30 MG in 30 ML Injection | PSN | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625129 | mosunetuzumab-axgb 1 MG in 1 ML Injection | PSN | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625137 | mosunetuzumab-axgb 30 MG in 30 ML Injection | PSN | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625135 | 1 ML mosunetuzumab-axgb 1 MG/ML Injection [Lunsumio] | SBD | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625138 | 30 ML mosunetuzumab-axgb 1 MG/ML Injection [Lunsumio] | SBD | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625129 | 1 ML mosunetuzumab-axgb 1 MG/ML Injection | SCD | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625137 | 30 ML mosunetuzumab-axgb 1 MG/ML Injection | SCD | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625135 | Lunsumio 1 MG per 1 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625135 | Lunsumio 1 MG/ML per 1 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625138 | Lunsumio 1 MG/ML per 30 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625138 | Lunsumio 30 MG per 30 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625129 | mosunetuzumab-axgb 1 MG per 1 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625129 | mosunetuzumab-axgb 1 MG/ML per 1 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625137 | mosunetuzumab-axgb 1 MG/ML per 30 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
| 2625137 | mosunetuzumab-axgb 30 MG per 30 ML Injection | SY | 2ef0cf38-101c-4681-98fe-c05dc9ead443 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50242-142-01 | 50242014201 | 1 VIAL in 1 CARTON (50242-142-01) / 30 mL in 1 VIAL | 1 vial | 2022-12-22 | 0000-00-00 | No | No | Current |